CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- 8-K Event Results of operations · Executive or director change · Regulation FD disclosure
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SC 13D Stake Beneficial Ownership Report
- 4 Open-market sale Former 10% Owner sold 797,987 shares at an average $1.51 ($1,201,680)
- 8-K Event Executive or director change
- 4 Open-market sale Chief Scientific Officer sold 598 shares at $1.26 ($753)
- 4 Open-market sale Chief Financial Officer sold 1,005 shares at $1.26 ($1,266)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale 10% owner sold 529,261 shares at $1.44 ($762,136)
- 8-K Event Other events
- EFFECT Other Notice of Effectiveness
- 8-K Event Executive or director change · Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Material agreement
- S-3 Offering Registration Statement
Page 36 of 41 · 802 filings